Following EMA approval, several European countries have resumed vaccination with AstraZeneca. Others like Ireland or Sweden have decided to wait to make the decision.
Germany, France, and Italy vaccinate against COVID again with the AstraZeneca formula started from Friday following the European Medicines Agency's recommendation (EMA).
The European body assured this Thursday that it does not see evidence that the AstraZeneca vaccine is directly related to thromboembolism cases detected after vaccination with this drug in different European countries and considered it safe to continue using it in immunization campaigns against COVID -19.
Italy has resumed vaccinations with this compound, but the Government has added a novelty: citizens who refuse to be vaccinated against COVID-19 with the AstraZeneca compound will be offered an alternative later.
"If someone is summoned to be vaccinated with the AstraZeneca vaccine and rejects it, they will be reconsidered later for another type of injection," said the head of Italy's Higher Health Council, Franco Locatelli, at a press conference.
In France, Prime Minister Jean Castex, 55, received his first dose of the AstraZeneca vaccine this Friday, intending to set an example and that the population is not suspicious of the vaccine.
It will include a warning.
The EMA will include a warning in the product information so that physicians are alert when reviewing the vaccine insert and monitoring any cases that may be related. He added that his experts have concluded that the AstraZeneca vaccine is "safe and effective" after two weeks of research. Still, He stressed that he could not completely rule out the relationship with rare thromboembolism cases, so he will continue to investigate.
Other countries such as Bulgaria, Latvia, Lithuania, Slovenia, or Cyprus have also announced that they will resume vaccination with AstraZeneca. For its part, Portugal will resume injections from next Monday, and the Netherlands will do so from next week. However, it has not specified a specific day.
On the contrary, territories such as Ireland or Sweden have ensured that they will still take "a few days" to decide on this vaccine.
Spain has also decided to resume vaccination after paralyzing it. Still, it will do so on Wednesday to follow various protocols and give security and confidence to the population, unlike these countries.
Experts from the Public Health Commission could recommend that it not be administered to certain population groups, such as young women - although age has not yet been decided. However, if they could recommend it for people over 65, it has not been applied until now.
As la Sexta has learned, this decision will be made at a meeting on vaccines to be held this weekend and in which the new technical sheet approved by Europe and the conclusions on the cases of thrombi will be analyzed. These cases are statistically very few, very rare, and occur mainly in women. Hence it is considered difficult to avoid vaccination of this population group.
Next Monday, there will be a meeting of the Interterritorial Health Council in which these issues will be decided based on the reports that the Public Health experts will make.